A recent study indicates that individuals who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.
Published data in a major health publication points out that while overweight people often shed a large proportion of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.
"People purchasing these medications must be aware of the potential of quick rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment weight within about 18 months.
Weighing Approaches
The study, which reviewed 37 of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with other pills.
Scientists emphasize that individuals who shed pounds through dieting usually experience a less rapid creep back—perhaps 0.1 kg a month—once they finish.
Explaining the Quick Regain
Doctors believe the way of the injections is key to understanding the accelerated rebound.
These medications mimic a body's own chemical called GLP-1, which moderates appetite.
"Artificially providing GLP-1 concentrations far above than normal may cause the system to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement results in hunger is no longer kept in check, making binge eating far more likely."
An Ongoing Issue?
Medical guidelines advise the injections for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts argue that, given the likelihood of weight regain, the therapy might need to be ongoing.
This perspective is reinforced by pharmaceutical companies, who state that the findings "highlight the long-term character of excess weight," akin to managing conditions like diabetes.
User Testimonies
People who have come off the medication explain a powerful resurgence of cravings.
"It was like a trigger flipping and you become ravenous," said one woman.
This difficulty is exacerbated if patients have not adopted sustainable lifestyle or habit changes during treatment.
Growing Interest
Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with interest being substantial.
- Use is higher among females than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
Ultimately, clinicians emphasize that while the jabs are potent tools for weight loss, they are not a permanent fix and long-term success hinges on ongoing lifestyle changes.
